Cargando…

A bispecific IgG format containing four independent antigen binding sites

Bispecific antibodies come in many different formats, including the particularly interesting two-in-one antibodies, where one conventional IgG binds two different antigens. The IgG format allows these antibodies to mediate Fc-related functionality, and their wild-type structure ensures low immunogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ljungars, Anne, Schiött, Torbjörn, Mattson, Ulrika, Steppa, Jessica, Hambe, Björn, Semmrich, Monika, Ohlin, Mats, Tornberg, Ulla-Carin, Mattsson, Mikael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994471/
https://www.ncbi.nlm.nih.gov/pubmed/32005942
http://dx.doi.org/10.1038/s41598-020-58150-z
_version_ 1783493197165494272
author Ljungars, Anne
Schiött, Torbjörn
Mattson, Ulrika
Steppa, Jessica
Hambe, Björn
Semmrich, Monika
Ohlin, Mats
Tornberg, Ulla-Carin
Mattsson, Mikael
author_facet Ljungars, Anne
Schiött, Torbjörn
Mattson, Ulrika
Steppa, Jessica
Hambe, Björn
Semmrich, Monika
Ohlin, Mats
Tornberg, Ulla-Carin
Mattsson, Mikael
author_sort Ljungars, Anne
collection PubMed
description Bispecific antibodies come in many different formats, including the particularly interesting two-in-one antibodies, where one conventional IgG binds two different antigens. The IgG format allows these antibodies to mediate Fc-related functionality, and their wild-type structure ensures low immunogenicity and enables standard methods to be used for development. It is however difficult, time-consuming and costly to generate two-in-one antibodies. Herein we demonstrate a new approach to create a similar type of antibody by combining two different variable heavy (VH) domains in each Fab arm of an IgG, a tetra-VH IgG format. The VHs are used as building blocks, where one VH is placed at its usual position, and the second VH replaces the variable light (VL) domain in a conventional IgG. VH domains, binding several different types of antigens, were discovered and could be rearranged in any combination, offering a convenient “plug and play” format. The tetra-VH IgGs were found to be functionally tetravalent, binding two antigens on each arm of the IgG molecule simultaneously. This offers a new strategy to also create monospecific, tetravalent IgGs that, depending on antigen architecture and mode-of-action, may have enhanced efficacy compared to traditional bivalent antibodies.
format Online
Article
Text
id pubmed-6994471
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-69944712020-02-06 A bispecific IgG format containing four independent antigen binding sites Ljungars, Anne Schiött, Torbjörn Mattson, Ulrika Steppa, Jessica Hambe, Björn Semmrich, Monika Ohlin, Mats Tornberg, Ulla-Carin Mattsson, Mikael Sci Rep Article Bispecific antibodies come in many different formats, including the particularly interesting two-in-one antibodies, where one conventional IgG binds two different antigens. The IgG format allows these antibodies to mediate Fc-related functionality, and their wild-type structure ensures low immunogenicity and enables standard methods to be used for development. It is however difficult, time-consuming and costly to generate two-in-one antibodies. Herein we demonstrate a new approach to create a similar type of antibody by combining two different variable heavy (VH) domains in each Fab arm of an IgG, a tetra-VH IgG format. The VHs are used as building blocks, where one VH is placed at its usual position, and the second VH replaces the variable light (VL) domain in a conventional IgG. VH domains, binding several different types of antigens, were discovered and could be rearranged in any combination, offering a convenient “plug and play” format. The tetra-VH IgGs were found to be functionally tetravalent, binding two antigens on each arm of the IgG molecule simultaneously. This offers a new strategy to also create monospecific, tetravalent IgGs that, depending on antigen architecture and mode-of-action, may have enhanced efficacy compared to traditional bivalent antibodies. Nature Publishing Group UK 2020-01-31 /pmc/articles/PMC6994471/ /pubmed/32005942 http://dx.doi.org/10.1038/s41598-020-58150-z Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Ljungars, Anne
Schiött, Torbjörn
Mattson, Ulrika
Steppa, Jessica
Hambe, Björn
Semmrich, Monika
Ohlin, Mats
Tornberg, Ulla-Carin
Mattsson, Mikael
A bispecific IgG format containing four independent antigen binding sites
title A bispecific IgG format containing four independent antigen binding sites
title_full A bispecific IgG format containing four independent antigen binding sites
title_fullStr A bispecific IgG format containing four independent antigen binding sites
title_full_unstemmed A bispecific IgG format containing four independent antigen binding sites
title_short A bispecific IgG format containing four independent antigen binding sites
title_sort bispecific igg format containing four independent antigen binding sites
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994471/
https://www.ncbi.nlm.nih.gov/pubmed/32005942
http://dx.doi.org/10.1038/s41598-020-58150-z
work_keys_str_mv AT ljungarsanne abispecificiggformatcontainingfourindependentantigenbindingsites
AT schiotttorbjorn abispecificiggformatcontainingfourindependentantigenbindingsites
AT mattsonulrika abispecificiggformatcontainingfourindependentantigenbindingsites
AT steppajessica abispecificiggformatcontainingfourindependentantigenbindingsites
AT hambebjorn abispecificiggformatcontainingfourindependentantigenbindingsites
AT semmrichmonika abispecificiggformatcontainingfourindependentantigenbindingsites
AT ohlinmats abispecificiggformatcontainingfourindependentantigenbindingsites
AT tornbergullacarin abispecificiggformatcontainingfourindependentantigenbindingsites
AT mattssonmikael abispecificiggformatcontainingfourindependentantigenbindingsites
AT ljungarsanne bispecificiggformatcontainingfourindependentantigenbindingsites
AT schiotttorbjorn bispecificiggformatcontainingfourindependentantigenbindingsites
AT mattsonulrika bispecificiggformatcontainingfourindependentantigenbindingsites
AT steppajessica bispecificiggformatcontainingfourindependentantigenbindingsites
AT hambebjorn bispecificiggformatcontainingfourindependentantigenbindingsites
AT semmrichmonika bispecificiggformatcontainingfourindependentantigenbindingsites
AT ohlinmats bispecificiggformatcontainingfourindependentantigenbindingsites
AT tornbergullacarin bispecificiggformatcontainingfourindependentantigenbindingsites
AT mattssonmikael bispecificiggformatcontainingfourindependentantigenbindingsites